Prevention of diabetes in NOD nice by administration of dendritic cells deficient in nuclear transcription factor-κB activity
Prevention of diabetes in NOD nice by administration of dendritic cells deficient in nuclear transcription factor-κB activity
复制标题
DOI:
10.2337/diabetes.52.8.1976
复制
发表时间:
2003-08-01
期刊:
影响因子:
7.7
通讯作者:
Lu, L
中科院分区:
文献类型:
--
作者:
Ma, LL;Qian, SG;Lu, L
Abnormalities of dendritic Cells (DCs) have been identified in type 1 diabetic patients and in nonobese diabetic (NOD) mice that are associated with augmented nuclear transcription factor (NF)-kappaB activity. An imbalance that favors development of the immunogenic DCs may predispose to the disease, and restoration of the balance by administration of DCs deficient in NF-kappaB activity may prevent diabetes., DCs propagated from NOD mouse bone marrow and treated with NF-kappaB-specific oligodeoxyribonucleotide (ODN) in vitro (NF-kappaB ODN DC) were assessed for efficacy in prevention of diabetes development in vivo. Gel shift,assay with DC nuclear extracts confirmed specific inhibition of NF-kappaB DNA binding by NF-kappaB ODN. The costimulatory molecule expression, interleukin (IL)-12 production, and immunostimulatory capacity in presenting allo- and islet-associated antigens by NF-kappaB ODN DC were significantly suppressed. NF-kappaB ODN renders DC resistant to lipopolysaccharide stimulation. Administration of 2 X 106 NF-kappaB ODN DCs into NOD mice aged 6-7 weeks effectively prevented the onset of diabetes. T-cells from pancreatic lymph nodes of NF-kappaB ODN DC-treated animals exhibited hyporesponsiveness to islet antigens with low production of interferon-gamma and IL-2. These findings provide novel insights into the mechanisms of autoimmune diabetes and may lead to development of novel preventive strategies.